4//SEC Filing
Ryali Sriram 4
Accession 0001209191-20-019001
CIK 0001305253other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:35 PM ET
Size
7.2 KB
Accession
0001209191-20-019001
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Award
Common Stock
2020-03-05$7.31/sh+229$1,674→ 1,628 total - Award
Stock Option (Right to Buy)
2020-03-12+65,000→ 65,000 totalExercise: $5.60Exp: 2030-03-11→ Common Stock (65,000 underlying)
Footnotes (2)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The option vests in equal monthly installments over 48 months measured from March 12, 2020 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001762893
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:35 PM ET
- Size
- 7.2 KB